BACKGROUND: To determine the benefit of contrast-enhanced ultrasound (CEUS) in the assessment of breast lesions. METHODS: A standardized contrast-enhanced ultrasound was performed in 230 breast lesions classified as BI-RADS category 3 to 5. All lesions were subjected to qualitative and quantitative analysis. MVI (MicroVascular Imaging) technique was used to derive qualitative analysis parameters; blood perfusion of the lesions was assessed (perfusion homogeneity, type of vascularization, enhancement degree). Quantitative analysis was conducted to estimate perfusion changes in the lesions within drawn regions of interest (ROI); parameters TTP (time to peak), PI (peak intensity), WIS (wash in slope), AUC (area under curve) were obtained from time intensity (TI) curves. Acquired data were statistically analyzed to assess the ability of each parameter to differentiate between malignant and benign lesions. The combination of parameters was also evaluated for the possibility of increasing the overall diagnostic accuracy. Biological nature of the lesions was verified by a pathologist. Benign lesions without histopathological verification (BI-RADS 3) were followed up for at least 24 months. RESULTS: Out of 230 lesions, 146 (64%) were benign, 67 (29%) were malignant, 17 (7%) lesions were eliminated. Malignant tumors showed statistically significantly lower TTP parameters (sensitivity 77.6%, specificity 52.7%) and higher WIS values (sensitivity 74.6%, specificity 66.4%) than benign tumors. Enhancement degree also proved to be statistically well discriminating as 55.2% of malignant lesions had a rich vascularity (sensitivity 89.6% and specificity 48.6%). The combination of quantitative analysis parameters (TTP, WIS) with enhancement degree did not result in higher accuracy in distinguishing between malignant and benign breast lesions. CONCLUSIONS: We have demonstrated that contrast-enhanced breast ultrasound has the potential to distinguish between malignant and benign lesions. In particular, this method could help to differentiate lesions BI-RADS category 3 and 4 and thus reduce the number of core-cut biopsies performed in benign lesions. Qualitative analysis, despite its subjective element, appeared to be more beneficial. A combination of quantitative and qualitative analysis did not increase the predictive capability of CEUS.

Department of Radiation Oncology Faculty of Medicine Masaryk University Brno Czech Republic

Department of Radiation Oncology Masaryk Memorial Cancer Institute Zluty kopec 7 65653 Brno Czech Republic

The Clinic of Internal Medicine Haematology and Oncology The University Hospital Brno Brno Czech Republic

The Clinic of Radiology and Nuclear Medicine Faculty of Medicine Masaryk University Brno Czech Republic

The Clinic of Radiology and Nuclear Medicine The University Hospital Brno Brno Czech Republic

The Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Brno Czech Republic

The Institute of Pathology The University Hospital Brno Brno Czech Republic

Zobrazit více v PubMed

Dusek L, Muzik J, Kubasek M, Koptikova J, Zaloudik J, Vyzula R. Epidemiology of malignant Tumours in the Czech Republic [online]. Masaryk University, Czech Republic, [2005], [cit. 2019-12-03]. http://www.svod.cz. Version 7.0 [2007], ISSN 1802–8861.

Svoboda M, Navrátil J, Fabian P, Palácová M, Gombošová J, Slámová L, et al. Triple-negative breast cancer: analysis of patients diagnosed and/or treated at the Masaryk memorial Cancer institute between 2004 and 2009. Klin Onkol. 2012;25(3):188–198. PubMed

Zhi H, Ou B, Luo B-M, Feng X, Wen Y-L, Yang H-Y. Comparison of ultrasound elastography, mammography, and sonography in the diagnosis of solid breast lesions. J Ultrasound Med. 2007;26(6):807–815. doi: 10.7863/jum.2007.26.6.807. PubMed DOI

Wang Z, Tang J, An L, Wang W, Luo Y, Li J, et al. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med. 2007;26(6):757–762. doi: 10.7863/jum.2007.26.6.757. PubMed DOI

Jia W-R, Chai W-M, Tang L, Wang Y, Fei X-C, Han B-S, et al. Three-dimensional contrast enhanced ultrasound score and dynamic contrast-enhanced magnetic resonance imaging score in evaluating breast tumor angiogenesis: correlation with biological factors. Eur J Radiol. 2014;83(7):1098–1105. doi: 10.1016/j.ejrad.2014.03.027. PubMed DOI

Quan J, Hong Y, Zhang X, Mei M, You X, Huang P. The clinical role of contrast enhanced ultrasound in differential diagnosis of BI-RADS 4 breast disease. Clin Hemorheol Microcirc. 2019;72(3):293–303. doi: 10.3233/CH-180495. PubMed DOI

Lee SC, Tchelepi H, Grant E, Desai B, Luo C, Groshen S, Hovanessian-Larsen L. Contrast-enhanced ultrasound imaging of breast masses: adjunct tool to decrease the number of false-positive biopsy results. J Ultrasound Med. 2019;38(9):2259–2273. doi: 10.1002/jum.14917. PubMed DOI PMC

Tang L, Chen Y, Du Z, Zhong Z, Chen Q, Yang L, et al. A multicenter study of a contrast-enhanced ultrasound diagnostic classification of breast lesions. Cancer Manag Res. 2019;11:2163–2170. doi: 10.2147/CMAR.S194868. PubMed DOI PMC

Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438(7070):932–936. doi: 10.1038/nature04478. PubMed DOI

Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182–1186. doi: 10.1056/NEJM197111182852108. PubMed DOI

Szabó BK, Saracco A, Tánczos E, Aspelin P, Leifland K, Wilczek B, et al. Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer. Eur Radiol. 2013;23(12):3228–3236. doi: 10.1007/s00330-013-2960-5. PubMed DOI

Zhou YH, Tan F, Hess KR, Yung WKA. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. Clin Cancer Res. 2003;9(9):3369–3375. PubMed

Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R, et al. Vascular endothelial growth factor polymorphisms in relation to breast Cancer development and prognosis. Clin Cancer Res. 2005;11(10):3647–3653. doi: 10.1158/1078-0432.CCR-04-1803. PubMed DOI

Linderholm B, Lindh B, Beckman L, Erlanson M, Edin K, Travelin B, et al. Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. Clin Breast Cancer. 2003;4(5):340–347. doi: 10.3816/CBC.2003.n.039. PubMed DOI

Ricci P, Cantisani V, Ballesio L, Pagliara E, Sallusti E, Drudi F, et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. Magnetic Resonance Imaging. Ultraschall Med. 2007;28(1):57–62. doi: 10.1055/s-2006-927226. PubMed DOI

Cao X-L, Bao W, Zhu S-G, Wang L-H, Sun M-H, Wang L, et al. Contrast-enhanced ultrasound characteristics of breast cancer: correlation with prognostic factors. Ultrasound Med Biol. 2014;40(1):11–17. doi: 10.1016/j.ultrasmedbio.2013.08.014. PubMed DOI

Du J, Li F-H, Fang H, Xia J-G, Zhu C-X. Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions. J Ultrasound Med. 2008;27(6):821–831. doi: 10.7863/jum.2008.27.6.821. PubMed DOI

Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions. Eur J Radiol. 2010;73(2):288–293. doi: 10.1016/j.ejrad.2009.05.043. PubMed DOI

Wan C, Du J, Fang H, Li F, Wang L. Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis. Eur J Radiol. 2012;81(4):e444–e450. doi: 10.1016/j.ejrad.2011.03.094. PubMed DOI

Du J, Wang L, Wan C-F, Hua J, Fang H, Chen J, et al. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. Eur J Radiol. 2012;81(12):3890–3899. doi: 10.1016/j.ejrad.2012.09.004. PubMed DOI

Chen Y, Tang L, Du Z, Zhong Z, Luo J, Yang L, et al. Factors influencing the performance of a diagnostic model including contrast-enhanced ultrasound in 1023 breast lesions: comparison with histopathology. Ann Transl Med. 2019;7(22):647. doi: 10.21037/atm.2019.10.83. PubMed DOI PMC

Kapetas P, Clauser P, Woitek R, Wengert GJ, Lazar M, Pinker K, et al. Quantitative multiparametric breast ultrasound: application of contrastenhanced ultrasound and elastography leads to an improved differentiation of benign and malignant lesions. Investig Radiol. 2019;54(5):257–264. doi: 10.1097/RLI.0000000000000543. PubMed DOI PMC

Kamei K, Kaneoka Y, Harada T, Maeda A, Imayoshi Y, Yoshida M, et al. Investigation of contrast-enhanced ultrasound findings for the differential diagnosis of small breast lesions. Ultrasound Med Biol. 2019;45:S43. doi: 10.1016/j.ultrasmedbio.2019.07.551. DOI

Shao SH, Li CX, Yao MH, Li G, Li X, Wu R. Incorporation of contrast-enhanced ultrasound in the differential diagnosis for breast lesions with inconsistent results on mammography and conventional ultrasound. Clin Hemorheol Microcirc. 2020. 10.3233/CH-190729. PubMed

Contrast-Enhanced Ultrasonography for Differential Diagnosis of Benign and Malignant Thyroid Lesions: Single-Institutional Prospective Study of Qualitative and Quantitative CEUS Characteristics